𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Oral Zinc Sulphate Supplementation for Six Months in SCA2 Patients: A Randomized, Double-Blind, Placebo-Controlled Trial

✍ Scribed by Luis Velázquez-Pérez; Jorge Rodríguez-Chanfrau; Julio Cesar García-Rodríguez; Gilberto Sánchez-Cruz; Raúl Aguilera-Rodríguez; Roberto Rodríguez-Labrada; Julio Cesar Rodríguez-Díaz; Nalia Canales-Ochoa; Dennis Almaguer Gotay; Luis E. Almaguer Mederos; José M. Laffita Mesa; Marlene Porto-Verdecia; Consuelo González Triana; Noemí Rodríguez Pupo; Idania Hidalgo Batista; Orestes D. López-Hernandez; Iverlis Díaz Polanco; Arelis Jayme Novas

Book ID
106484790
Publisher
Springer
Year
2011
Tongue
English
Weight
334 KB
Volume
36
Category
Article
ISSN
0364-3190

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Creatine supplements in patients with id
Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: Six-month, double-blind, randomized, placebo-controlled trial
✍ Chung, Yuen-li ;Alexanderson, Helene ;Pipitone, Nicoló ;Morrison, Catherine ;Das 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

## Abstract ## Objective To test the hypothesis that oral creatine supplements with exercise are more effective than exercise alone in improving muscle function in patients with established dermatomyositis or polymyositis receiving chronic medical therapies who are clinically weak yet stable. ##

Six-month results of a double-blind, pla
Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis
✍ J. Brandt; A. Khariouzov; J. Listing; H. Haibel; H. Sörensen; L. Grassnickel; M. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 2 views

## Abstract ## Objective There is increasing evidence that tumor necrosis factor α (TNFα) is centrally involved in the pathogenesis of ankylosing spondylitis (AS) and other spondylarthritides. This study was designed to investigate the efficacy of anti‐TNFα therapy with etanercept, a 75‐kd recepto